Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease

Erik V. Soloff; Atif Zaheer; Jeffrey Meier; Marc Zins; Eric P. Tamm

doi:10.1007/s00261-017-1410-2

Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease

Erik V. Soloff, Atif Zaheer, Jeffrey Meier, Marc Zins, Eric P. Tamm

School of Medicine

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite ongoing research, surgical resection remains the only potentially curative treatment. Therefore, accurate identification of those patients who would benefit from surgical resection is of paramount importance. High-quality imaging and image interpretation is central to this process. Radiology helps in the determination of whether patients are resectable, borderline resectable, or unresectable and guides treatment planning.

Original language	English (US)
Pages (from-to)	301-313
Number of pages	13
Journal	Abdominal Radiology
Volume	43
Issue number	2
DOIs	https://doi.org/10.1007/s00261-017-1410-2
State	Published - Feb 1 2018

Keywords

Pancreatic ductal adenocarcinoma (PDAC)
Preoperative staging
Resectability
Vasculature

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging
Gastroenterology
Urology

Access to Document

10.1007/s00261-017-1410-2

Cite this

@article{0222e54fd389423d97c4e182c34548af,

title = "Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease",

abstract = "Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite ongoing research, surgical resection remains the only potentially curative treatment. Therefore, accurate identification of those patients who would benefit from surgical resection is of paramount importance. High-quality imaging and image interpretation is central to this process. Radiology helps in the determination of whether patients are resectable, borderline resectable, or unresectable and guides treatment planning.",

keywords = "Pancreatic ductal adenocarcinoma (PDAC), Preoperative staging, Resectability, Vasculature",

author = "Soloff, {Erik V.} and Atif Zaheer and Jeffrey Meier and Marc Zins and Tamm, {Eric P.}",

note = "Funding Information: Conflict of interest Erik Soloff, Atif Zaheer, Jeffrey Meier, and Marc Zins declares that they have no conflict of interest. Eric Tamm declares in-kind research grant from GE unrelated to this paper.",

year = "2018",

month = feb,

day = "1",

doi = "10.1007/s00261-017-1410-2",

language = "English (US)",

volume = "43",

pages = "301--313",

journal = "Abdominal Radiology",

issn = "2366-004X",

publisher = "Springer New York",

number = "2",

}

TY - JOUR

T1 - Staging of pancreatic cancer

T2 - resectable, borderline resectable, and unresectable disease

AU - Soloff, Erik V.

AU - Zaheer, Atif

AU - Meier, Jeffrey

AU - Zins, Marc

AU - Tamm, Eric P.

N1 - Funding Information: Conflict of interest Erik Soloff, Atif Zaheer, Jeffrey Meier, and Marc Zins declares that they have no conflict of interest. Eric Tamm declares in-kind research grant from GE unrelated to this paper.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite ongoing research, surgical resection remains the only potentially curative treatment. Therefore, accurate identification of those patients who would benefit from surgical resection is of paramount importance. High-quality imaging and image interpretation is central to this process. Radiology helps in the determination of whether patients are resectable, borderline resectable, or unresectable and guides treatment planning.

AB - Pancreatic ductal adenocarcinoma (PDAC) is a relatively common malignancy that carries an overall poor prognosis, with five-year survival below 10%. Despite ongoing research, surgical resection remains the only potentially curative treatment. Therefore, accurate identification of those patients who would benefit from surgical resection is of paramount importance. High-quality imaging and image interpretation is central to this process. Radiology helps in the determination of whether patients are resectable, borderline resectable, or unresectable and guides treatment planning.

KW - Pancreatic ductal adenocarcinoma (PDAC)

KW - Preoperative staging

KW - Resectability

KW - Vasculature

UR - http://www.scopus.com/inward/record.url?scp=85035781380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035781380&partnerID=8YFLogxK

U2 - 10.1007/s00261-017-1410-2

DO - 10.1007/s00261-017-1410-2

M3 - Article

C2 - 29198002

AN - SCOPUS:85035781380

SN - 2366-004X

VL - 43

SP - 301

EP - 313

JO - Abdominal Radiology

JF - Abdominal Radiology

IS - 2

ER -

Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this